US Patent 9492553 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods

Patent 9492553 was granted and assigned to Genentech on November, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9492553

Date of Patent

November 15, 2016

Patent Application Number

14254067

Date Filed

April 16, 2014

Patent Citations Received

‌

US Patent 11986535 Method of producing an immunoligand/payload conjugate

‌

US Patent 11833120 Binding protein drug conjugates comprising anthracycline derivatives

Patent Primary Examiner

‌

Yan Xiao

Patent abstract

The present invention relates to antibody-drug conjugate compounds of Formula I:Ab-(L-D)p I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9492553 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API